STEMI patients with diabetes show higher mortality following PCI

09/23/2013 | Healio

Diabetes patients who underwent percutaneous coronary intervention for STEMI had nearly four times the mortality rate of those without diabetes, according to results from the INFUSE-AMI trial. Researchers also found those with diabetes had more extensive left anterior descending artery disease and a higher 30-day revascularization rate compared with the nondiabetes cohort. The findings appear in the journal Catheterization and Cardiovascular Interventions.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC